Latest News

Journal Articles

Autoimmune

Autoantibodies in neurological disorders – a review from Judith Greer

Immunotherapy for mild cognitive impairment patients: a role for omega-3 fatty acids in improving innate immunity against amyloid-beta

NCTalks with Robyn Klein: immunology and inflammation in neurological disease

Cerebrovascular disease

Spider venom affords neuroprotection after stroke

Orthostatic hypotension could contribute to risk of dementia

Post-stroke neurogenesis boosted with new compound

CNS/PNS/SNS

IL4I1 decreases inflammation and promotes CNS repair in models of multiple sclerosis

Current update of adoptive immunotherapy using cytokine-induced killer cells to eliminate malignant gliomas

NCTalks with Emery Brown – understanding the brain under general anesthesia

Cognitive/neurodegenerative disorders

AAN 2017: Two clinical studies report promising data for new spinal muscular atrophy treatment

AAN17: Phase III study reports the positive effects of an “old” drug for the treatment of advanced Parkinson’s disease

Repurposed drugs prevent neurodegeneration in mice in breakthrough study

Demyelinating disease

IL4I1 decreases inflammation and promotes CNS repair in models of multiple sclerosis

AAN17: Potential novel treatment for multiple sclerosis identified

Autoantibodies in neurological disorders – a review from Judith Greer

Development and pediatrics

AAN 2017: Two clinical studies report promising data for new spinal muscular atrophy treatment

First live-attenuated Zika vaccine induces protective immunity in mice

Increased cerebrospinal fluid could be used as biomarker for autism

Epilepsy and seizure

AAN17: Study demonstrates cannabis-based medicine may reduce epileptic seizures

Stress could be a powerful trigger of epileptic seizures

A path from bench to bedside in sudden death in epilepsy (SUDEP) – an opinion from Mark Stewart

Genetics

Is there a role for pharmacogenetics in the dosing of fentanyl?

Huntington’s researchers provide new insight into disease mechanism

Webinar Q&A follow-up: How chronic stress experienced during early development epigenetically programs adult disease risk

Headache

Electrical stimulation could provide pain relief alternative for migraines

Psychological mislabeling of chronic pain: lessons from migraine in the 20th century

The best of 2016 on Neurology Central – a note from the Editor

Immune disorders and inflammation

Autoantibodies in neurological disorders – a review from Judith Greer

Immunotherapy for mild cognitive impairment patients: a role for omega-3 fatty acids in improving innate immunity against amyloid-beta

NCTalks with Robyn Klein: immunology and inflammation in neurological disease

Infection

Researchers uncover how Zika virus might cross the placental barrier

How does Zika virus affect our neural cells?

The cytopathic effects of Zika virus: has new research discovered what is to blame?

Injury/trauma

AAN2017: neurotrauma and sports neurology

White matter changes in patients with mild traumatic brain injury: MRI perspective

Epidural stimulation therapy helps paralyzed patient regain movement

Movement disorders

AAN17: Phase III study reports the positive effects of an “old” drug for the treatment of advanced Parkinson’s disease

Deep brain stimulation for Parkinson's disease: current status and future outlook

The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease

Neuro-ophthalmology

Genetic analysis identifies loci associated with macular telangiectasia type 2

The best of 2016 on Neurology Central – a note from the Editor

Individual retinal ganglion cells imaged with new technique

Neurometabolic

Could the gut microbiome hold the key to neurodegenerative disorders?

The best of 2016 on Neurology Central – a note from the Editor

Energy drinks and alcohol may affect adolescent brains in similar way to cocaine

Neuromuscular

Mitochondrial DNA homeostasis dysregulated in Parkinson’s disease

Antibody show promise against multiple sclerosis

The best of 2016 on Neurology Central – a note from the Editor

Neuropsychiatry

Webinar Q&A follow-up: How chronic stress experienced during early development epigenetically programs adult disease risk

Deep brain stimulation could be an effective treatment option for severe Tourette’s syndrome

Could doxycycline prevent or treat post-traumatic stress disorder?

Oncology/tumor

Current update of adoptive immunotherapy using cytokine-induced killer cells to eliminate malignant gliomas

Global, genome-wide glioma study identifies new genetic risk factors

Largest ever brain cancer study identifies 13 novel genetic errors

Pain

Is there a role for pharmacogenetics in the dosing of fentanyl?

Transcutaneous electrical nerve stimulation: current status of evidence

New gene-editing technology could relieve chronic pain

Sleep

Webinar Q&A follow-up: How chronic stress experienced during early development epigenetically programs adult disease risk

Precision medicine in circadian rhythm sleep–wake disorders: current state and future perspectives

The best of 2016 on Neurology Central – a note from the Editor